Puerto Rico Technology Today
SEE OTHER BRANDS

Get your fresh news on science and technology in Puerto Rico

Puerto Rico Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.

Press releases published on August 26, 2025

UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
JOYY Reports Second Quarter 2025 Unaudited Financial Results
Quick Custom Intelligence Welcomes Industry Veteran Melissa Chiaurro as Vice President of Business Development
JAMining Announces Milestone of Over 8 Million Registered Users Driving Global Expansion
Axonius Appoints Joe Diamond President to Lead Unified Go-To-Market Organization for Next Phase of Growth
ZenaTech firma una oferta para adquirir una empresa británica de diseño y modelado 3D del sector de telecomunicaciones, ampliando su presencia europea en Drones como un Servicio (DaaS)
BlackLine To Host Investor Session at BeyondTheBlack 2025
Louis Bélanger-Martin Taps Australian Market for High-Impact Aviation Tech Pilots
Sana Biotechnology to Present at September 2025 Investor Conferences
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Immuneering Announces Closing of $25 Million Private Placement
Pulmonx to Participate in September Investor Conferences
iMDx to Participate in NYC Investment Conferences September 8 - 11
3D Systems Receives $7.65 Million Contract Award from U.S. Air Force for Advanced Metal Printing System
Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary
nCino Reports Second Quarter Fiscal Year 2026 Financial Results
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
CompoSecure Highlights its Arculus Onchain Tap-to-Pay Capability and Showcases Innovation at Stablecoin Conference LATAM 2025
Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions